{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:54:29Z","timestamp":1793022869621,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16J10320"],"award-info":[{"award-number":["JP16J10320"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00134-017-5004-9","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T05:21:47Z","timestamp":1512364907000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis\/septic shock: a systematic review with meta-analysis and trial sequential analysis"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3854-4081","authenticated-orcid":false,"given":"Tomoko","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Ganeko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Featherstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pasero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bagshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"5004_CR1","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2014.2637","volume":"311","author":"KM Kaukonen","year":"2014","unstructured":"Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R (2014) Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000\u20132012. JAMA 311:1308\u20131316","journal-title":"JAMA"},{"key":"5004_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.13836","author":"C Rhee","year":"2017","unstructured":"Rhee C, Dantes R, Epstein L et al (2017) CDC prevention epicenter program: benchmarking the incidence and mortality of severe sepsis in the United States. JAMA. \n                    https:\/\/doi.org\/10.1001\/jama.2017.13836\n                    \n                   (Epub ahead of print)","journal-title":"JAMA"},{"key":"5004_CR3","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/cc12598","volume":"17","author":"JP Quenot","year":"2013","unstructured":"Quenot JP, Binquet C, Kara F et al (2013) The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care 17:R65","journal-title":"Crit Care"},{"key":"5004_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1164\/rccm.201310-1875OC","volume":"189","author":"A Leligdowicz","year":"2014","unstructured":"Leligdowicz A, Dodek PM, Norena M, Co-operative Antimicrobial Therapy of Septic Shock Database Research Group et al (2014) Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 189:1204\u20131213","journal-title":"Am J Respir Crit Care Med"},{"key":"5004_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"5004_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.2011.909","volume":"306","author":"AF Suffredini","year":"2011","unstructured":"Suffredini AF, Munford RS (2011) Novel therapies for septic shock over the past 4 decades. JAMA 306:194\u2013199","journal-title":"JAMA"},{"key":"5004_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","volume":"32","author":"RP Dellinger","year":"2004","unstructured":"Dellinger RP, Carlet JM, Masur H, Surviving Sepsis Campaign Management Guidelines Committee et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858\u2013873","journal-title":"Crit Care Med"},{"key":"5004_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580\u2013637","journal-title":"Crit Care Med"},{"key":"5004_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1378\/chest.99.1.169","volume":"99","author":"RL Danner","year":"1991","unstructured":"Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE (1991) Endotoxemia in human septic shock. Chest 99:169\u2013175","journal-title":"Chest"},{"key":"5004_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.7326\/0003-4819-119-8-199310150-00001","volume":"119","author":"LC Casey","year":"1993","unstructured":"Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771\u2013778","journal-title":"Ann Intern Med"},{"key":"5004_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/422254","volume":"190","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Foster D, Vincent JL, MEDIC study et al (2004) Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 190:527\u2013534","journal-title":"J Infect Dis"},{"key":"5004_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1744-9987.1998.tb00066.x","volume":"2","author":"H Shoji","year":"1998","unstructured":"Shoji H, Tani T, Hanasawa K, Kodama M (1998) Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther Apher 2:3\u201312","journal-title":"Ther Apher"},{"key":"5004_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1046\/j.1526-0968.2003.00005.x","volume":"7","author":"H Shoji","year":"2003","unstructured":"Shoji H (2003) Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 7:108\u2013114","journal-title":"Ther Apher Dial"},{"key":"5004_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/01.shk.0000159930.87737.8a","volume":"23","author":"JL Vincent","year":"2005","unstructured":"Vincent JL, Laterre PF, Cohen J et al (2005) A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23:400\u2013405","journal-title":"Shock"},{"key":"5004_CR15","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R et al (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301:2445\u20132452","journal-title":"JAMA"},{"key":"5004_CR16","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/cc5780","volume":"11","author":"DN Cruz","year":"2007","unstructured":"Cruz DN, Perazella MA, Bellomo R et al (2007) Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 11:R47","journal-title":"Crit Care"},{"key":"5004_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"DM Payen","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, ABDOMIX Group et al (2015) Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 41:975\u2013984","journal-title":"Intensive Care Med"},{"key":"5004_CR18","volume-title":"EUPHRATES: evaluating the use of polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock","author":"P Dellinger","year":"2016","unstructured":"Dellinger P (2016) EUPHRATES: evaluating the use of polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock. Canadian Critical Care Forum, Toronto"},{"key":"5004_CR19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097","journal-title":"PLoS Med"},{"key":"5004_CR20","doi-asserted-by":"publisher","first-page":"e012908","DOI":"10.1136\/bmjopen-2016-012908","volume":"6","author":"T Fujii","year":"2016","unstructured":"Fujii T, Ganeko R, Kataoka Y, Featherstone R, Bagshaw S, Furukawa TA (2016) Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis\/septic shock: a protocol for a systematic review and meta-analysis. BMJ Open 6:e012908","journal-title":"BMJ Open"},{"key":"5004_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","volume":"29","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, International Sepsis Definitions Conference et al (2003) 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference. Intensive Care Med 29:530\u2013538","journal-title":"Intensive Care Med"},{"key":"5004_CR22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"JL Vincent","year":"1998","unstructured":"Vincent JL, de Mendon\u00e7a A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European Society of Intensive Care Medicine. Crit Care Med 26:1793\u20131800","journal-title":"Crit Care Med"},{"key":"5004_CR23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jclinepi.2008.10.012","volume":"62","author":"M Sampson","year":"2009","unstructured":"Sampson M, McGowana J, Cogob E, Grimshaw J, Moherd D, Lefebvre C (2009) An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol 62:944\u2013952","journal-title":"J Clin Epidemiol"},{"key":"5004_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184","volume-title":"Cochrane handbook for Systematic Reviews of Interventions","author":"JPT Higgins","year":"2008","unstructured":"Higgins JPT, Green S (2008) Cochrane handbook for Systematic Reviews of Interventions. John Wiley & Sons, Chichester (UK)"},{"key":"5004_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707\u2013710","journal-title":"Intensive Care Med"},{"key":"5004_CR26","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1097\/00003246-200111000-00002","volume":"29","author":"R Cook","year":"2001","unstructured":"Cook R, Cook D, Tilley J, Lee K, Marshall J, Canadian Critical Care Trials Group (2001) Multiple organ dysfunction: baseline and serial component scores. Crit Care Med 29:2046\u20132050","journal-title":"Crit Care Med"},{"key":"5004_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jclinepi.2013.03.009","volume":"66","author":"BR da Costa","year":"2013","unstructured":"da Costa BR, N\u00fcesch E, Rutjes AW et al (2013) Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. J Clin Epidemiol 66:847\u2013855","journal-title":"J Clin Epidemiol"},{"key":"5004_CR28","unstructured":"Review Manager (RevMan) [Computer program] (2014) Version 5.3. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen"},{"key":"5004_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"5004_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383\u2013394","journal-title":"J Clin Epidemiol"},{"key":"5004_CR31","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s00134-008-1124-6","volume":"34","author":"V Cantaluppi","year":"2008","unstructured":"Cantaluppi V, Assenzio B, Pasero D et al (2008) Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 34:1638\u20131645","journal-title":"Intensive Care Med"},{"key":"5004_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/jhin.2002.1332","volume":"53","author":"T Nakamura","year":"2003","unstructured":"Nakamura T, Ushiyama C, Suzuki Y et al (2003) Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus. J Hosp Infect 53:58\u201363","journal-title":"J Hosp Infect"},{"key":"5004_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000333826","volume":"32","author":"P Berto","year":"2011","unstructured":"Berto P, Ronco C, Cruz D, Melotti RM, Antonelli M (2011) Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy. Blood Purif 32:331\u2013340","journal-title":"Blood Purif"},{"key":"5004_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/1745-6215-15-218","volume":"15","author":"DJ Klein","year":"2014","unstructured":"Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP (2014) The EUPHRATES trial (evaluating the use of polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock): study protocol for a randomized controlled trial. Trials. 15:218","journal-title":"Trials."},{"key":"5004_CR35","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1097\/00003246-200011000-00001","volume":"28","author":"PM Honore","year":"2000","unstructured":"Honore PM, Jamez J, Wauthier M et al (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581\u20133587","journal-title":"Crit Care Med"},{"key":"5004_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1164\/ajrccm.161.5.9809127","volume":"161","author":"R Bellomo","year":"2000","unstructured":"Bellomo R, Kellum JA, Gandhi CR et al (2000) The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161:1429\u20131436","journal-title":"Am J Respir Crit Care Med"},{"key":"5004_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00134-006-0118-5","volume":"32","author":"R Cornejo","year":"2006","unstructured":"Cornejo R, Downey P, Castro R et al (2006) High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32:713\u2013722","journal-title":"Intensive Care Med"},{"key":"5004_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMoa0802639","volume":"359","author":"VA\/NIH Acute Renal Failure Trial Network","year":"2008","unstructured":"VA\/NIH Acute Renal Failure Trial Network (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7\u201320","journal-title":"N Engl J Med"},{"key":"5004_CR39","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","volume":"361","author":"RENAL Replacement Therapy Study Investigators","year":"2009","unstructured":"RENAL Replacement Therapy Study Investigators (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627\u20131638","journal-title":"N Engl J Med"},{"key":"5004_CR40","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/CCM.0b013e3181d9d912","volume":"38","author":"R Van Wert","year":"2010","unstructured":"Van Wert R, Friedrich JO, Scales DC et al (2010) High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med 38:1360\u20131369","journal-title":"Crit Care Med"},{"key":"5004_CR41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/CCM.0b013e3181962316","volume":"37","author":"D Payen","year":"2009","unstructured":"Payen D, Mateo J, Cavaillon JM et al (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803\u2013810","journal-title":"Crit Care Med"},{"key":"5004_CR42","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1097\/CCM.0b013e31828cf412","volume":"41","author":"F Zhou","year":"2013","unstructured":"Zhou F, Peng Z, Murugan R, Kellum JA (2013) Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 41:2209\u20132220","journal-title":"Crit Care Med"},{"key":"5004_CR43","doi-asserted-by":"publisher","first-page":"e858","DOI":"10.1097\/CCM.0000000000002362","volume":"45","author":"T Chang","year":"2017","unstructured":"Chang T, Tu YK, Lee CT et al (2017) Effects of polymyxin b hemoperfusion on mortality in patients with severe sepsis and septic shock: a systemic review, meta-analysis update, and disease severity subgroup meta-analysis. Crit Care Med 45:e858\u2013e864","journal-title":"Crit Care Med"},{"key":"5004_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000046966","volume":"19","author":"H Nemoto","year":"2001","unstructured":"Nemoto H, Nakamoto H, Okada H et al (2001) Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 19:361\u2013368","journal-title":"Blood Purif"},{"key":"5004_CR45","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s00134-004-2357-7","volume":"30","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Kawagoe Y, Matsuda T, Koide H (2004) Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis. Intensive Care Med 30:1838\u20131841","journal-title":"Intensive Care Med"},{"key":"5004_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000045752","volume":"86","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Ushiyama C, Suzuki S et al (2000) Effect of polymyxin B-immobilized fiber hemoperfusion on sepsis-induced rhabdomyolysis with acute renal failure. Nephron 86:210","journal-title":"Nephron"},{"key":"5004_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00002480-200201000-00010","volume":"48","author":"T Nakamura","year":"2002","unstructured":"Nakamura T, Ushiyama C, Shoji H, Koide H (2002) Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis. ASAIO J 48:41\u201344","journal-title":"ASAIO J"},{"key":"5004_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00002480-200205000-00008","volume":"48","author":"T Nakamura","year":"2002","unstructured":"Nakamura T, Ushiyama C, Suzuki Y, Shoji H, Shimada N, Koide H (2002) Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma. ASAIO J 48:244\u2013248","journal-title":"ASAIO J"},{"key":"5004_CR49","first-page":"c33","volume":"94","author":"T Nakamura","year":"2003","unstructured":"Nakamura T, Ushiyama C, Suzuki Y et al (2003) Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis. Nephron 94:c33\u2013c39","journal-title":"Nephron"},{"key":"5004_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/SHK.0000000000000725","volume":"47","author":"R Coudroy","year":"2017","unstructured":"Coudroy R, Payen D, Launey Y, ABDOMIX Group et al (2017) Modulation by polymyxin-B hemoperfusion of inflammatory response related to severe peritonitis. Shock. 47:93\u201399","journal-title":"Shock."}],"updated-by":[{"DOI":"10.1007\/s00134-018-5055-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000}}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-017-5004-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-5004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-5004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T18:08:07Z","timestamp":1589566087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-017-5004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["5004"],"URL":"https:\/\/doi.org\/10.1007\/s00134-017-5004-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00134-018-5055-6","asserted-by":"object"}]},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]},"assertion":[{"value":"30 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Owing to an oversight by the authors, Figure\u00a02 in this article was not the version intended for publication. The correct Figure\u00a02, reproduced here, features footnote symbols and Figure\u00a02b includes three studies as described in the main text.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TF is supported by the Japan Society for the Promotion of Science (JSPS) and has received a grant from JSPS. This study was funded in part by Grant-in-Aid for JSPS Research Fellow JP16J10320 to TF. SMB is supported by a Canada Research Chair in Critical Care Nephrology and is a steering committee member of the EUPHRATES trial. He has consulted and received speaking fees from Baxter Healthcare Corp. TAF has received lecture fees from Eli Lilly, Janssen, Meiji, Mitsubishi-Tanabe, MSD, and Pfizer. He has received royalties from Igaku-Shoin and Nihon Bunka Kagaku-sha publishers. He has received research support from Mitsubishi-Tanabe and Mochida. KD received lecture fees from Asahi Kasei Medical Crop, Baxter Healthcare Corp., and Toray Medical Corp. JLV, DP, RB, and CR were engaged in the clinical trials included in this review, and provided some of the data not reported in their published papers. None of these funding organizations have contributed to the study design; collection, management, analysis, and interpretation of data; writing of the report, or the decision to submit the report for publication. Toray Industries provided some of the data included in this review, as noted in the body of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}